Value of caregiver ratings in evaluating the quality of life of patients with cancer

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1206-1217

  Sneeuw, K C ^a   Aaronson, N K ^a   Sprangers, M A ^a   Detmar, S B ^a   Wever, L D ^a   Schornagel, J H ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CAREGIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL ANALYSIS;

EID: 0031043827     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1206     Document Type: Article

References (52)

1. Osoba D: Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12:608-616, 1994
2. Spilker B: Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA, Lippincott-Raven, 1996
3. Sprangers MA, Aaronson NK: The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. J Clin Epidemiol 45:743-760, 1992
4. Coates A, Gebski V, Bishop JF, et al: Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med 317:1490-1495, 1987
5. Finkelstein DM, Cassileth BR, Bonomi PD, et al: A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. Am J Clin Oncol 11:630-633, 1988
6. Ganz PA, Haskell CM, Figlin RA, et al: Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer 61:849-856, 1988
7. Hurny C, Bernhard J, Joss R, et al: Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer - A lesson from the real world. Ann Oncol 3:825-831, 1992
8. Loizou LA, Rampton D, Atkinson M, et al: A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 70:386-391, 1992
9. Medical Research Council Lung Cancer Working Party: A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC) II: Quality of life. Br J Cancer 68:1157-1166, 1993
10. Hopwood P, Stephens RJ, Machin D: Approaches to the analysis of quality of life data: Experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual Life Res 3:339-352, 1994
11. Aaronson NK: Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutions. Eur J Cancer 28A:1304-1307, 1992
12. Fairclough DL, Gelber RD: Quality of life: Statistical issues and analysis, in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA, Lippincott-Raven, 1996, pp 427-435
13. Nelson EC, Berwick DM: The measurement of health status in clinical practice. Med Care 27:S77-S90, 1989 (suppl)
14. Schor EL, Lerner DJ, Malspeis S: Physicians' assessment of functional health status and well-being: The patient's perspective. Arch Intern Med 155:309-314, 1995
15. Pearlman RA, Uhlmann RF, Jecker NS: Spousal understanding of patient quality of life: Implications for surrogate decisions. J Clin Ethics 3:114-121, 1992
16. Gough IR, Dalgleish LI: What value is given to quality of life assessment by health professionals considering response to palliative chemotherapy for advanced cancer? Cancer 68:220-225, 1991
17. Nayfield SG, Ganz PA, Moinpour CM, et al: Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1:203-210, 1992
18. Slevin ML, Plant H, Lynch D, et al: Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109-112, 1988
19. Spitzer WO, Dobson AJ, Hall J, et al: Measuring the quality of life of cancer patients: A concise QL-index for use by physicians. J Chronic Dis 34:585-597, 1981
20. Selby PJ, Chapman JA, Etazadi Amoli J, et al: The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50:13-22, 1984
21. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C-30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
22. Blazeby JM, Williams MH, Alderson D, et al: Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg 82:1200-1203, 1995
23. Sneeuw KCA, Aaronson NK, Osoba D, et al: The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (in press)
24. Hays RD, Anderson R, Revicki D: Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 2:441-449, 1993
25. Nunnally JC, Bernstein IH: Psychometric theory. New York, NY, McGraw-Hill, 1994
26. Gotay CC: Patient-reported assessment versus performance-based tests, in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA, Lippincott-Raven, 1996, pp 413-420
27. Rubenstein LZ, Schairer C, Wieland GD, et al: Systematic biases in functional status assessment of elderly adults: Effects of different data sources. J Gerontol 39:686-691, 1984
28. Farrow DC, Samet JM: Comparability of information provided by elderly cancer patients and surrogates regarding health and functional status, social network, and life events. Epidemiology 1:370-376, 1990
29. Van Weel C: Functional status in primary care: COOP/ WONCA charts. Disabil Rehabil 15:96-101, 1993
30. Scholten JHG, Van Weel C: Functional Status Assessment in Family Practice: The Dartmouth COOP Functional Health Assessment Charts/WONCA. Lelystad, the Netherlands, Meditekst, 1992
31. Van Weel C, König-Zahn C, Touw-Otten FWMM, et al: Measuring Functional Health Status With the COOP/WONCA Charts: A Manual. Groningen, the Netherlands, Northern Centre of Health Care Research, 1995
32. Nelson E, Wasson J, Kirk J, et al: Assessment of function in routine clinical practice: Description of the COOP chart method and preliminary findings. J Chron Dis 40:55S-69S, 1987 (suppl 1)
33. Nelson EC, Landgraf JM, Hays RD, et al: The COOP function charts: A system to measure patient function in physicians' offices, in Lipkin M (ed): Functional Status Measurement in Primary Care. New York, NY, Springer-Verlag, 1990, pp 97-131
34. Osoba D, Rodrigues G, Myles J, et al: Significance of changes in health-related quality of life (QOL) scores in women receiving chemotherapy for recurrent or metastatic breast cancer. Qual Life Res 4:468-469, 1995
35. Zubrod CG, Schneiderman M, Frei E, et al: Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 11:7-33, 1960
36. Conill C, Verger E, Salamero M: Performance status assessment in cancer patients. Cancer 65:1864-1866, 1990
37. Bartko JJ: The intraclass correlation coefficient as a measure of reliability. Psychol Rep 19:3-11, 1966
38. Deyo RA, Diehr P, Patrick DL: Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials 12:142S-158S, 1991 (suppl)
39. Lee J, Koh D, Ong CN: Statistical evaluation of agreement between two methods for measuring a quantitative variable. Comput Biol Med 19:61-70, 1989
40. Fleiss JL, Cohen J: The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 33:613-619, 1973
41. Cohen J: The t-test for means, in Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ, Lawrence Erlbaum, 1988, pp 19-74
42. Ware JE, Kosinski M, Bayliss MS, et al: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care 33:AS264-AS279, 1995
43. Liang MH, Larson MG, Cullen KE, et al: Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 28:542-547, 1985
44. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310, 1986
45. Nelson LM, Longstreth WT, Koepsell TD, et al: Proxy respondents in epidemiologic research. Epidemiol Rev 12:71-86, 1990
46. Hjermstad MJ, Fossa SD, Bjordal K, et al: Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13:1249-1254, 1995
47. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
48. Hodgkins M, Albert D, Daltroy L: Comparing patients' and their physicians' assessments of pain. Pain 23:273-277, 1985
49. Grossman SA, Sheidler VR, Swedeen K, et al: Correlation of patient and caregiver ratings of cancer pain. J Pain Sympt Manage 6:53-57, 1991
50. Au E, Loprinzi CL, Dhodapkar M, et al: Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity. J Clin Oncol 12:2751-2755, 1994
51. De Haan R, Aaronson NK, Limburg M, et al: Measuring quality of life in stroke. Stroke 24:320-327, 1993
52. McHorney CA, Ware JE, Rogers W, et al: The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts: Results from the Medical Outcomes Study. Med Care 30:MS253-MS265, 1992